Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1 study found for:    23719718 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed A Study of Brivanib (BMS-582664) in Patients With Liver Cancer and Mild, Moderate or Severe Liver Dysfunction
Condition: Carcinoma, Hepatocellular
Intervention: Drug: Brivanib

Study has passed its completion date and status has not been verified in more than two years.